Efficacy of combination of rituximab therapy with chlorambucil plus prednisolone (R-LP) Protocol as treatment line in chronic lymphocytic leukemia patients
Background: Chronic lymphocytic leukemia (CLL) remains an incurable disease with variable course. It is typically responsive to several courses of chemotherapy. Objectives: Evaluation of efficacy of combination of rituximab with chlorambucil plus prednisolone (R-LP) as first line of treatment of CLL...
Main Author: | Waseem F Al Tameemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Iraqi Journal of Hematology |
Subjects: | |
Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2015;volume=4;issue=1;spage=1;epage=15;aulast=Al;type=0 |
Similar Items
-
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01) -
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
by: Casado LF, et al.
Published: (2016-09-01) -
Chlorambucil effect on B lymphocites in the peripheral blood of patients with chronic lymphocytic leukemia: Cell ultrastructure investigation
by: Brajušković Goran R., et al.
Published: (2003-01-01) -
Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
by: Seiter K, et al.
Published: (2015-06-01) -
Chronic Lymphocytic Leukemia in Elderly Patients: Own Experience
by: Vyhovska O., et al.
Published: (2017-03-01)